192 related articles for article (PubMed ID: 34241550)
1. Radiomic Features at CT Can Distinguish Pancreatic Cancer from Noncancerous Pancreas.
Chen PT; Chang D; Yen H; Liu KL; Huang SY; Roth H; Wu MS; Liao WC; Wang W
Radiol Imaging Cancer; 2021 Jul; 3(4):e210010. PubMed ID: 34241550
[TBL] [Abstract][Full Text] [Related]
2. Deep learning to distinguish pancreatic cancer tissue from non-cancerous pancreatic tissue: a retrospective study with cross-racial external validation.
Liu KL; Wu T; Chen PT; Tsai YM; Roth H; Wu MS; Liao WC; Wang W
Lancet Digit Health; 2020 Jun; 2(6):e303-e313. PubMed ID: 33328124
[TBL] [Abstract][Full Text] [Related]
3. CT Radiomic Features of Superior Mesenteric Artery Involvement in Pancreatic Ductal Adenocarcinoma: A Pilot Study.
Rigiroli F; Hoye J; Lerebours R; Lafata KJ; Li C; Meyer M; Lyu P; Ding Y; Schwartz FR; Mettu NB; Zani S; Luo S; Morgan DE; Samei E; Marin D
Radiology; 2021 Dec; 301(3):610-622. PubMed ID: 34491129
[TBL] [Abstract][Full Text] [Related]
4. Validation of Prognostic Radiomic Features From Resectable Pancreatic Ductal Adenocarcinoma in Patients With Advanced Disease Undergoing Chemotherapy.
Salinas-Miranda E; Khalvati F; Namdar K; Deniffel D; Dong X; Abbas E; Wilson JM; O'Kane GM; Knox J; Gallinger S; Haider MA
Can Assoc Radiol J; 2021 Nov; 72(4):605-613. PubMed ID: 33151087
[TBL] [Abstract][Full Text] [Related]
5. Radiomics-based Machine-learning Models Can Detect Pancreatic Cancer on Prediagnostic Computed Tomography Scans at a Substantial Lead Time Before Clinical Diagnosis.
Mukherjee S; Patra A; Khasawneh H; Korfiatis P; Rajamohan N; Suman G; Majumder S; Panda A; Johnson MP; Larson NB; Wright DE; Kline TL; Fletcher JG; Chari ST; Goenka AH
Gastroenterology; 2022 Nov; 163(5):1435-1446.e3. PubMed ID: 35788343
[TBL] [Abstract][Full Text] [Related]
6. Differentiating autoimmune pancreatitis from pancreatic ductal adenocarcinoma with CT radiomics features.
Park S; Chu LC; Hruban RH; Vogelstein B; Kinzler KW; Yuille AL; Fouladi DF; Shayesteh S; Ghandili S; Wolfgang CL; Burkhart R; He J; Fishman EK; Kawamoto S
Diagn Interv Imaging; 2020 Sep; 101(9):555-564. PubMed ID: 32278586
[TBL] [Abstract][Full Text] [Related]
7. Utility of CT Radiomics Features in Differentiation of Pancreatic Ductal Adenocarcinoma From Normal Pancreatic Tissue.
Chu LC; Park S; Kawamoto S; Fouladi DF; Shayesteh S; Zinreich ES; Graves JS; Horton KM; Hruban RH; Yuille AL; Kinzler KW; Vogelstein B; Fishman EK
AJR Am J Roentgenol; 2019 Aug; 213(2):349-357. PubMed ID: 31012758
[No Abstract] [Full Text] [Related]
8. Quantitative Radiomic Features From Computed Tomography Can Predict Pancreatic Cancer up to 36 Months Before Diagnosis.
Chen W; Zhou Y; Asadpour V; Parker RA; Puttock EJ; Lustigova E; Wu BU
Clin Transl Gastroenterol; 2023 Jan; 14(1):e00548. PubMed ID: 36434803
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic accuracy of unenhanced CT texture analysis to differentiate mass-forming pancreatitis from pancreatic ductal adenocarcinoma.
Ren S; Zhao R; Zhang J; Guo K; Gu X; Duan S; Wang Z; Chen R
Abdom Radiol (NY); 2020 May; 45(5):1524-1533. PubMed ID: 32279101
[TBL] [Abstract][Full Text] [Related]
10. Predicting pancreatic ductal adenocarcinoma using artificial intelligence analysis of pre-diagnostic computed tomography images.
Qureshi TA; Gaddam S; Wachsman AM; Wang L; Azab L; Asadpour V; Chen W; Xie Y; Wu B; Pandol SJ; Li D
Cancer Biomark; 2022; 33(2):211-217. PubMed ID: 35213359
[TBL] [Abstract][Full Text] [Related]
11. Exploratory analysis of mesenteric-portal axis CT radiomic features for survival prediction of patients with pancreatic ductal adenocarcinoma.
Rigiroli F; Hoye J; Lerebours R; Lyu P; Lafata KJ; Zhang AR; Erkanli A; Mettu NB; Morgan DE; Samei E; Marin D
Eur Radiol; 2023 Aug; 33(8):5779-5791. PubMed ID: 36894753
[TBL] [Abstract][Full Text] [Related]
12. Radiomic feature reproducibility in contrast-enhanced CT of the pancreas is affected by variabilities in scan parameters and manual segmentation.
Yamashita R; Perrin T; Chakraborty J; Chou JF; Horvat N; Koszalka MA; Midya A; Gonen M; Allen P; Jarnagin WR; Simpson AL; Do RKG
Eur Radiol; 2020 Jan; 30(1):195-205. PubMed ID: 31392481
[TBL] [Abstract][Full Text] [Related]
13. Risk of Neoplastic Progression in Individuals at High Risk for Pancreatic Cancer Undergoing Long-term Surveillance.
Canto MI; Almario JA; Schulick RD; Yeo CJ; Klein A; Blackford A; Shin EJ; Sanyal A; Yenokyan G; Lennon AM; Kamel IR; Fishman EK; Wolfgang C; Weiss M; Hruban RH; Goggins M
Gastroenterology; 2018 Sep; 155(3):740-751.e2. PubMed ID: 29803839
[TBL] [Abstract][Full Text] [Related]
14. CT Abnormalities of the Pancreas Associated With the Subsequent Diagnosis of Clinical Stage I Pancreatic Ductal Adenocarcinoma More Than 1 Year Later: A Case-Control Study.
Toshima F; Watanabe R; Inoue D; Yoneda N; Yamamoto T; Sasahira N; Sasaki T; Matsuyama M; Minehiro K; Tateishi U; Gabata T
AJR Am J Roentgenol; 2021 Dec; 217(6):1353-1364. PubMed ID: 34161128
[No Abstract] [Full Text] [Related]
15. CT radiomics associations with genotype and stromal content in pancreatic ductal adenocarcinoma.
Attiyeh MA; Chakraborty J; McIntyre CA; Kappagantula R; Chou Y; Askan G; Seier K; Gonen M; Basturk O; Balachandran VP; Kingham TP; D'Angelica MI; Drebin JA; Jarnagin WR; Allen PJ; Iacobuzio-Donahue CA; Simpson AL; Do RK
Abdom Radiol (NY); 2019 Sep; 44(9):3148-3157. PubMed ID: 31243486
[TBL] [Abstract][Full Text] [Related]
16. CT Radiomics-Based Preoperative Survival Prediction in Patients With Pancreatic Ductal Adenocarcinoma.
Park S; Sham JG; Kawamoto S; Blair AB; Rozich N; Fouladi DF; Shayesteh S; Hruban RH; He J; Wolfgang CL; Yuille AL; Fishman EK; Chu LC
AJR Am J Roentgenol; 2021 Nov; 217(5):1104-1112. PubMed ID: 34467768
[No Abstract] [Full Text] [Related]
17. CT Density in the Pancreas is a Promising Imaging Predictor for Pancreatic Ductal Adenocarcinoma.
Fukuda Y; Yamada D; Eguchi H; Hata T; Iwagami Y; Noda T; Asaoka T; Kawamoto K; Gotoh K; Kobayashi S; Takeda Y; Tanemura M; Mori M; Doki Y
Ann Surg Oncol; 2017 Sep; 24(9):2762-2769. PubMed ID: 28634666
[TBL] [Abstract][Full Text] [Related]
18. Deep Convolutional Neural Network-Assisted Feature Extraction for Diagnostic Discrimination and Feature Visualization in Pancreatic Ductal Adenocarcinoma (PDAC) versus Autoimmune Pancreatitis (AIP).
Ziegelmayer S; Kaissis G; Harder F; Jungmann F; Müller T; Makowski M; Braren R
J Clin Med; 2020 Dec; 9(12):. PubMed ID: 33322559
[TBL] [Abstract][Full Text] [Related]
19. Risk prediction of pancreatic cancer using AI analysis of pancreatic subregions in computed tomography images.
Javed S; Qureshi TA; Gaddam S; Wang L; Azab L; Wachsman AM; Chen W; Asadpour V; Jeon CY; Wu B; Xie Y; Pandol SJ; Li D
Front Oncol; 2022; 12():1007990. PubMed ID: 36439445
[TBL] [Abstract][Full Text] [Related]
20. Differentiation of hypovascular pancreatic neuroendocrine tumors from pancreatic ductal adenocarcinoma using contrast-enhanced computed tomography.
Ren S; Chen X; Wang Z; Zhao R; Wang J; Cui W; Wang Z
PLoS One; 2019; 14(2):e0211566. PubMed ID: 30707733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]